Speaker(s): 

Sreelatha Naik, MD, Staff Member, Geisinger - has nothing to disclose.

Moderator(s): 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Access the pathophysiologic mechanisms contributing to obesity hypoventilation syndrome (OHS) and their implications in therapeutic decision-making

  Contrast the impact of treatment modalities in OHS.

   

  Synthesize pathophysiologic insights, literature evidence and reimbursement guidelines to design personalized, evidence-based strategies for PAP therapy in OHS

•  

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Manoj Suryanarayanan, MD; Sreelatha Naik, MD; Caroline Baran, MD; Jamie Karlotski, CRNP and Kimberly Persaud, DO have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session:

None.